Adam Levin, MD is a Resident in the Department of Psychiatry and Behavioral Health at the Ohio State University School of Medicine and an Affiliate Scholar at the Center for Psychedelic Drug Research and Education (CPDRE) in the Ohio State University College of Social Work. He has worked on the design and implementation of a clinical trial of psilocybin-assisted therapy in Veterans with PTSD and has lead several surveys focused on the interactions between drug policy, medical education and practice. In the summer of 2024, he will begin a Post-Doctoral Fellowship with the CPDRE, where his team will continue their work with Veterans and begin another clinical trial comparing psilocybin- to 5-MeO-DMT- assisted therapy for the treatment of patients with depression and lung cancer.